NSC |
Compound |
Enrichment |
Correlation |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0208632511155817 |
0.35617195 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0208632511155817 |
0.3805388 |
NSC 295641 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.0208632511155817 |
-0.016550283 |
NSC 317908 |
Null |
0.0208632511155817 |
0.17806809 |
NSC 627778 |
Null |
0.0208632511155817 |
0.03155976 |
NSC 631306 |
cis-Amminedichloro(4-methoxyphenethylamine)platinum(II) |
0.0208632511155817 |
0.45415153 |
NSC 641233 |
2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- |
0.0208632511155817 |
0.37369149 |
NSC 641297 |
ANTINEOPLASTIC-641297 |
0.0208632511155817 |
0.22637664 |
NSC 643813 |
3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] |
0.0208632511155817 |
0.28816162 |
NSC 646610 |
Null |
0.0208632511155817 |
0.25616582 |